Amsterdam, 6 May 2026 (Regulated Information) — AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) reports first quarter 2026 adjusted EBITDA of $44 million. This was a 2% improvement compared to the $43 million in the fourth quarter of 2025 and exceeded our guidance that the first quarter 2026 would be down sequentially. This better-than-expected performance in the current quarter was mainly driven by AMG Vanadium which included the consolidation of AURA beginning January 1, 2026. Beyond circular molybdenum, AURA brought recycled tungsten into our critical materials portfolio, and the tungsten price performance helped their results. Despite anticipated lower cash generation at the beginning of the year, AMG ended the quarter with a strong balance sheet highlighted by our $403 million of total liquidity as of March 31,...

HighlightsFollowing the announcement of GN Store Nord’s divestment of its Hearing division, the financial performance related hereto is treated as discontinued operations in the Q1 2026 report and until closing of the transaction. The Hearing division continued its recent strong market share momentum and delivered 9% organic revenue growth in the quarter. Supported by the strong organic revenue growth, the Hearing division delivered an adj. EBITA of DKK 300 million, equivalent to an adj. EBITA margin of 17.1% The Enterprise division delivered organic revenue growth of -5%. The business grew strongly in North America and APAC but declined in EMEA due to continued weak demand and channel inventory reductions. The launch of Evolve3 is progressing well driving significant growth in the premium segment of headsets. The contribution from the...

Banco Comercial Português, S.A. informs about consolidated earnings in Q1 2026AttachmentsEarningsPres 03M262026.05.06 Earnings Millennium BCP 1Q2026_f

CLEARWATER, Fla., May 06, 2026 (GLOBE NEWSWIRE) — via IBN — MedWell Ai, Inc, (OTCQB:MWAI) (“Company”) is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and wellness sectors, is pleased to confirm the filing, of its Quarterly Report (Form 10-Q), for the financial period, ending on March 31, 2026. Key Financial Highlights: Increased Total Revenues:For three months, ended March 31, 2026, Company had generated total revenues of $618,676 ($638,336 including deferred revenues) vs $281,318, for three months, ended March 31, 2025. For nine months, ended March 31, 2026, Company had generated total revenues of $1,694,482 vs $425,327, for nine months, ended March 31, 2025. The Company reconfirms yearly revenue guidance of $2.3 million.Reduced Total Loss From Operations:For...

MONTREAL, May 06, 2026 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (RSI) will be holding a conference call to discuss their 2026 second quarter results on Thursday, May 7th, 2026, at 5:30 p.m. (Eastern Time). The conference call will be chaired by Mr. Michael Walton, Chief Executive Officer and Mr. Jean-Sébastien Couillard, Chief Financial Officer. If you wish to participate, please dial 1-800-717-1738. A recording of the conference call will be accessible shortly after the conference, by dialing 1-888-660-6264, access code 52000#. This recording will be available until June 7, 2026. The discussion along with a presentation will be accessible through a webcast at the following address: https://onlinexperiences.com/Launch/QReg/ShowUUID=22C402D7-09B4-4AE7-B8A9-0564E00ED728&LangLocaleID=1033 For further information: Jean-Sébastien Couillard...

LONDON, May 06, 2026 (GLOBE NEWSWIRE) — First Quarter Financial Highlights.On May 6, 2026, pursuant to the Company’s capital return policy (the “Capital Return Policy”), the Board of Directors of the Company declared a cash dividend of $0.07 per share of the Company’s common stock for the quarter ended March 31, 2026, payable on June 10, 2026, to all shareholders of record as of the close of business U.S. Eastern Time on May 20, 2026 (the “Dividend”). The aggregate amount of the Dividend is expected to be approximately $4.3 million, which the Company anticipates will be funded from cash on hand.Also as part of the Company’s Capital Return Policy for the quarter ended March 31, 2026, the Company expects to repurchase approximately $6.3 million of its common stock between May 8, 2026, and June 30,...

– Global 4WARD Phase 3 Chronic Neutropenia Trial On Track to Complete Enrollment by the end of Q3 2026 – – European Commission Approval of XOLREMDI® (Mavorixafor) Provides the First and Only Authorized Treatment for Patients with WHIM Syndrome in the European Union – – Balance Sheet Provides Cash Runway through 2028 – BOSTON, May 06, 2026 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today reported financial results for the first quarter ended March 31, 2026 and provided a corporate update. “Our top priority remains the execution and full enrollment of the pivotal 4WARD Phase 3 trial of mavorixafor in chronic neutropenia,” said Adam Craig, M.D., Ph.D., Executive Chairman of X4 Pharmaceuticals. “We remain...

— Reaffirms 2026 Guidance — — Signed Three New Commercial Site Transfer Programs in First Quarter 2026 — — Cost Containment Initiatives Continue to Drive Down Expenses — Conference Call Today at 8:00am ET CHASKA, Minn., May 06, 2026 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced results for the first quarter ended March 31, 2026. CEO Commentary “During the first quarter, Lifecore continued to successfully execute the three pillars of its growth strategy – maximizing our existing commercial business, advancing our development pipeline toward commercialization, and adding high-quality, new programs to our pipeline through business development. We believe our continued...

~ Raises Fiscal 2026 Revenue Guidance and Introduces Fiscal 2026 Earnings Guidance ~ LONG ISLAND CITY, N.Y., May 06, 2026 (GLOBE NEWSWIRE) — Steven Madden, Ltd. (Nasdaq: SHOO) (the “Company”), a leading designer and marketer of fashion-forward footwear, accessories and apparel, today announced financial results for the first quarter ended March 31, 2026. Amounts referred to as “Adjusted” are non-GAAP measures that exclude the items defined as “Non-GAAP Adjustments” in the “Non-GAAP Reconciliation” section. First Quarter 2026 ResultsRevenue increased 18.0% to $653.1 million, compared to $553.5 million in the same period of 2025. Gross profit as a percentage of revenue was 54.7%, compared to 40.9% in the same period of 2025. Adjusted gross profit as a percentage of revenue was 46.3%, compared to 40.9% in the same period of 2025. Operating...

HOUSTON, May 06, 2026 (GLOBE NEWSWIRE) — Natural Resource Partners L.P. (NYSE:NRP) today reported first quarter 2026 results as follows:    For the Three Months Ended     Last Twelve Months Ended  (In thousands) (Unaudited)   March 31, 2026  Net income   $ 19,619     $ 115,733  Operating cash flow     33,014       164,453                   Free cash flow before investment in soda ash business     33,772       167,396  Investment in soda ash business     (39,200 )     (39,200 )Free cash flow(1)     (5,428 )     128,196  ____________________(1) See “Non-GAAP Financial Measures” and reconciliation tables at the end of this release.Highlights:Generated $33.8 million of free cash flow in the first quarter of 2026 before the $39.2 million capital investment in its soda ash business Paid...